Benefit-risk profile of intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) in CIDP: The path study

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: 0d969a772def091622388b6950098c7f18e7a3f9
First added on: Feb 11, 2025